By activating the TLR7 signaling pathway, GS-9620 induces the production of cytokines such as interferon and inhibits the replication of hepatitis B virus, and is being studied as a therapeutic option for chronic hepatitis B. Here, TLR7 is linked to chronic hepatitis B virus infection.